Related Experiment Video
Updated: May 25, 2026

Establishment of a Clinic-based Biorepository
Published on: May 29, 2017
Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the
Ling Gao1, Shuo Huang, Wenhao Ren
1Department of Oral Maxillofacial Surgery, Stomatological Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi, People's Republic of China.
Abstract:
The Jun activation domain-binding protein 1 (Jab1) may be involved in degradation of the cyclin-dependent kinase inhibitor p27, but it has not been clarified. In this study, we observed expression levels of Jab1 and p27 in oral squamous cell carcinoma (OSCC) and normal oral mucosa tissue and evaluated whether the Jab1 expression is correlated with p27 protein levels and how it is clinically relevant OSCC. The clinicopathological features and immunohistochemical expression levels of Jab1 and p27 proteins were immunohistochemically studied in 206 specimens from patients who underwent surgical resection for OSCC. Survival analyses were performed by using the Kaplan-Meier method. Jab1 overexpression was detected in 83% (171 of 206) of OSCCs and 19% (4 of 21) of normal oral mucosa. While p27 expression was 60% in OSCCs. We found an inverse correlation between Jab1 and p27 expression levels (P<0.001). Kaplan-Meier survival analysis showed that Jab1 overexpression and p27 low expression were significantly associated with poor prognosis of patients. Our findings suggest that Jab1 expression is inversely correlated with p27 expression levels, suggesting that Jab1 overexpression contributes to pathogenesis of OSCC by degradating p27 expression. Furthermore, control of Jab1 could be a novel target of therapy in OSCCs.
Insights
Jun activation domain-binding protein 1 (Jab1) overexpression correlates with poor prognosis in oral squamous cell carcinoma (OSCC). Jab1 may degrade p27, suggesting Jab1 as a potential therapeutic target for OSCC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Jun activation domain-binding protein 1 (Jab1) is a potential regulator of cyclin-dependent kinase inhibitor p27 degradation.
- The precise role of Jab1 in oral squamous cell carcinoma (OSCC) pathogenesis remains unclear.
Purpose of the Study:
- To investigate Jab1 and p27 expression levels in OSCC and normal oral mucosa.
- To evaluate the correlation between Jab1 expression and p27 protein levels.
- To determine the clinical relevance of Jab1 expression in OSCC prognosis.
Main Methods:
- Immunohistochemical analysis of Jab1 and p27 expression in 206 OSCC specimens and normal oral mucosa.
- Correlation analysis between Jab1 and p27 expression levels.
- Kaplan-Meier survival analysis to assess the association with patient prognosis.
Main Results:
- Jab1 was overexpressed in 83% of OSCCs compared to 19% in normal oral mucosa.
- p27 expression was observed in 60% of OSCCs.
- A significant inverse correlation was found between Jab1 and p27 expression (P<0.001).
- Jab1 overexpression and low p27 expression were significantly associated with poor patient prognosis.
Conclusions:
- Jab1 overexpression is inversely correlated with p27 expression in OSCC.
- Jab1 may contribute to OSCC pathogenesis by promoting p27 degradation.
- Jab1 represents a potential therapeutic target for OSCC.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
